Cargando…
Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
Centrosome amplification (CA) is a hallmark of cancer, observable in ≥75% of breast tumors. CA drives aggressive cellular phenotypes such as chromosomal instability (CIN) and invasiveness. Thus, assessment of CA may offer insights into the prognosis of breast cancer and identify patients who might b...
Autores principales: | Ogden, Angela, Rida, Padmashree C. G., Aneja, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428291/ https://www.ncbi.nlm.nih.gov/pubmed/28325915 http://dx.doi.org/10.1038/s41598-017-00363-w |
Ejemplares similares
-
The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
por: Mahathre, Monica M., et al.
Publicado: (2016) -
Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015) -
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
por: Pannu, Vaishali, et al.
Publicado: (2015) -
Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
por: Ogden, A, et al.
Publicado: (2014) -
KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
por: Pawar, Shrikant, et al.
Publicado: (2014)